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Genetics in eating disorders: extending
the boundaries of research
Genética em transtornos alimentares: ampliando
os horizontes de pesquisa
Abst rac t
Objective: To review the recent literature relevant to genetic research in eating disorders and to discuss unique issues which are
crucial for the development of a genetic research project in eating disorders in Brazil. Method: A computer literature review was
conducted in the Medline database between 1984 and may 2005 with the search terms “eating disorders”, “anorexia nervosa”,
“bulimia nervosa”, “binge eating disorder”, “family”, “twin” and “molecular genetic” studies. Results: Current research findings
suggest a substantial influence of genetic factors on the liability to anorexia nervosa and bulimia nervosa. Genetic research with
admixed populations should take into consideration sample size, density of genotyping and population stratification. Through
admixture mapping it is possible to study the genetic structure of admixed human populations to localize genes that underlie
ethnic variation in diseases or traits of interest. Conclusions: The development of a major collaborative genetics initiative of
eating disorders in Brazil and South America would represent a realistic possibility of studying the genetics of eating disorders in
the context of inter ethnic groups, and also integrate a new perspective on the biological etiology of eating disorders.
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Resumo
Objetivo: Revisar a literatura atual concernente à pesquisa genética em transtornos do comportamento alimentar e discutir
questões relevantes ao desenvolvimento de um projeto de pesquisa genética nessa área no Brasil. Método: A revisão realizada
utilizou a base de dados Medline, no período de 1984 a maio de 2005, com os seguintes termos de busca: “anorexia nervosa”,
“bulimia nervosa”, “eating disorders”, “binge eating disorder”, “family studies”, “twin studies”, “molecular genetics studies”. Resul-
tados: Os dados atuais apontam para uma contribuição relevante dos fatores genéticos na suscetibilidade à anorexia e à bulimia
nervosa. A pesquisa genética com populações miscigenadas deve levar em consideração o tamanho da amostra, a densidade de
genotipagem e a estratificação populacional. Através de “admixture mapping” é possível estimar a estrutura genética destas
populações e localizar genes relacionados à variação étnica de doenças ou traços de interesse. Conclusões: O desenvolvimento
de uma grande iniciativa de colaboração em genética de transtornos alimentares no Brasil e na América Latina viabilizará estudar
os fatores genéticos em transtornos do comportamento alimentar no contexto de grupos inter-étnicos, e integrar uma nova
perspectiva biológica à etiologia destes distúrbios.
Descritores: Anorexia nervosa; Bulimia nervosa; Transtornos da alimentação; Genética; Genética molecular
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Int roduct ion
Eating disorders – psychiatric disorders characterized by severe
disturbances in eating behavior that typically have onset during
late adolescence and young adulthood – are divided into three
major types: anorexia nervosa (AN), bulimia nervosa (BN), and
eating disorder not otherwise specified (EDNOS). AN is
characterized by obsessive fear of weight gain, severe eating
restriction, low body weight, and amenorrhea in women. BN
can occur at any body weight and is characterized by episodes
of binge-eating – the uncontrolled consumption of large
quantities of food in a very short period of time and compensatory
weight-loss behaviors. Some investigators have defined EDNOS
as atypical eating disorders and refer to them as those conditions
that meet the definition of an eating disorder but not the criteria
for AN or BN. Finally, binge eating disorder (BED) accounts for
a large proportion of individuals categorized as EDNOS1 and it
is also characterized by episodes of binge-eating except that the
individuals do not use any form of compensatory behaviors (i.e.
vomiting, laxatives, fasting, etc.). In addition, the prevalence of
overweight or obesity is elevated in individuals with BED.2
The average estimate of the current prevalence of AN is
280 per 100,000 young females (i.e., 0.28%). The average
current prevalence of BN among young females, using strict
diagnostic criteria, is about 1,000 per 100,000 (i.e. 1.0%).3
Community-based studies have generated prevalence figures
for BED in the region of 2-3% of the adult population and 8%
of the obese population. Higher rates of BED (20-40%) have
been reported in obese patients seeking weight loss treatment.2
AN has the highest mortality rate among psychiatric disorders
- 5% per decade.4 It is also grossly elevated in comparison to
individuals with no AN. A review (not a meta-analysis) of 60
outcome studies on BN reported a crude mortality rate of 0.3%.5
The mortality risk associated with bulimia nervosa is likely to
be elevated, although the actual morbidity and mortality
associated with BN remains unclear and deserves future
research.6 As for BED, mortality risk is associated with the
health consequences of overweight and obesity, although
recent findings show that negative health effects of binge eating
appear to be independent of obesity risk.7
Over the past 30 years, eating disorders have generally been
conceptualized as almost exclusively determined by environmental
factors such as family dynamics8-9 or cultural influences from
the media (e.g., societal pressures toward the slender ideal).10
The idea that eating disorders were merely culture-bound
syndromes was predominant until recently, but multiple lines of
research findings are challenging the exclusive causal role of
socio-cultural influences. In clinical samples, eating disorders
are strongly associated with various other categories of
psychopathological disturbance such as mood, anxiety, substance-
use and personality disorders, meaning that particular psychiatric
disorders or traits might represent expressions of a shared genetic
diathesis.11 The influence of genetic factors on the etiology of
eating disorders has been demonstrated in both family12-13 and
twin studies.14-18 Molecular genetic studies have also begun to
identify areas of the genome and candidate genes that might
uniquely influence the risk for eating disorders.11,18-24
This paper presents a synthesis of the current knowledge
about the genetic factors implicated in the etiology of eating
disorders. The unique implications of conducting genetic
studies on populations that represent a mixture of different
ancestries will be also addressed as patterns of genetic influence
and heritability might be influenced by cultural and ethnic
factors. The goals of this paper are two-fold: first, to review
the state of science relevant to genetic research in eating
disorders and second, to highlight issues that are unique to
the translation and development of genetic research in eating
disorders in Brazil and other admixed populations.
Family and twin studies
Family studies are designed to elucidate if a certain disorder
runs in families. This is often the first step in determining
whether genes may influence a specific disorder. It has long
been known that AN and BN cluster in families and controlled
family studies suggest that relatives of probands with eating
disorders have approximately a ten-fold greater lifetime risk of
having the disorders than relatives of unaffected controls.12,25-
26 Evidence of familial aggregation emerged for both AN and
BN, with a higher relative risk for AN.12-13,25,27 Furthermore,
additional studies12-13,25,28 have demonstrated co-aggregation of
the two disorders, indicating possible shared famil ial
vulnerabilities across eating disorders. It is also worth
mentioning that there is a higher risk for a range of eating
disorders in relatives of individuals with eating disorders rather
than a disorder-specific pattern of familial aggregation.12-13,25
Family studies are incapable of separating the genetic and
environmental components of transmission. Twin studies, in
contrast, are able to decompose variance in liability to a trait
into independent genetic and environmental sources and
provide est imates of  their  re lat ive magnitude. Since
monozygotic twins (MZ) are assumed to be genetically
identical, any differences between a pair of MZ twins result
from environmental influences. In contrast, differences between
dizygotic twins (DZ) could be due to either genetic or
environmental influences. Thus, comparing the similarity of
MZ twins and DZ twins provides information about the relative
contributions of genetic and environmental factors in the
etiology of the disorder. Twin studies on eating disorders have
demonstrated that a considerable portion of the observed
familiality is due to additive genetic factors.14-16,29 Twin studies
have estimated the heritability of AN to be between 33% and
84%,17 and the heritability of BN to be between 28% and
83%14 with the remaining variance (in both disorders) ascribed
to individual specific environmental factors, and negligible
impact of shared environmental factors. Many traits related to
eating disorders have also a heritable component. These include
binge-eating, self-induced vomiting, drive for thinness, dietary
restraint and dishinibition.14 Data from the Virginia Twin Registry
generated heritability estimates for binge eating and vomiting
of 46% and 70%, respectively.30
Some basic concepts of genetics need to be introduced.
Heritability is the proportion of the population variation in a
trait (e.g., body mass index) that can be explained by genetic
factors. Additive genetic factors refer to the impact of several
genes of small to moderate effect on liability to the trait under
study. Shared environment refers to environmental facts to
which both members of a twin pair are exposed such as
socioeconomic status, religion or origin, parental rearing style.
Shared environmental factors contribute to similarities between
members of a twin pair. Unique environment refers to
environmental circumstances that are experienced by only one
member of a twin pair. The estimate of unique environment
also includes measurement error.
Association and linkage studies
The acknowledgement that eating disorders have in part a
genetic basis has led to molecular studies aimed at finding
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genetic vulnerability factors. Association studies compare ca-
ses that display a trait of interest with controls who do not
display the trait, and genotype all individuals for a candidate
gene or genes that are hypothesized to be of relevance to the
phenotype. Statistical analysis compares genotype frequencies
in cases versus controls.31 The association approach is the
most appropriate when there is substantial prior knowledge of
the pathophysiology of a trait that could suggest specific
candidate genes. Where the pathophysiology of a disease is
not well understood, finding a susceptibility gene using the
candidate gene approach alone may involve as much luck as
judgment. A false positive result can occur, however, in an
admixed or stratified population if a trait is more prevalent in
one ethnic group and if the frequency of the genetic marker
also differs by ethnicity. There is also the risk of a false positive
finding due to multiple statistical tests given the enormous
number of genes in the human genome and the increasing
easiness to obtain genotypes.32
Linkage analysis requires a large sample of multiplex
pedigrees or extreme sibling pairs (pairs that are concordant
for high values, low values, or extremely discordant pairs for
the trait).33 Anonymous genetic markers scattered across the
genome are used to identify chromosomal regions harboring
genes that influence the trait of interest. If the marker and the
disease loci are adjacent, then the offspring who inherited
the disease gene should have also inherited the same allele at
the marker locus. The shared marker allele is “identical by
descent” to indicate that the alleles observed in the children
are copies of the same parental allele. If a particular locus is
involved in susceptibility to the disorder under study, then pairs
of siblings with that disease should inherit the same copy of
that locus more often than expected by chance. Linkage studies
help in narrowing the search space on the human genome.
Candidate genes located under the linkage peaks can be further
explored using association approaches to determine whether
they may actually be associated with the target trait.
The current literature describing the associations between
candidate genes and eating disorders has sporadically rendered
significant and frequently unreplicated findings.21-22 Candidate
gene studies in eating disorders have so far focused on genes
encoding proteins implicated in the regulation of feeding and
body composition, and genes involved in neurotransmitter
pathways regulating behavior. Genes implicated in the
serotonergic neurotransmission have also been evaluated
because of the potency of serotonin as an appetite suppressant
and its involvement in some of the traits associated with eating
disorders such as obsessive and perfectionist behavior.34-37
Promising research areas include the genetics of feeding and
weight regulation and the serotonergic system. Positive findings
on agouti-related protein gene,38 and uncoupling proteins39
require replication. Several studies on serotonin receptors have
been conducted and produced conflicting results: serotonin
receptor 2A,40-44 serotonin receptor 2C45-46 and serotonin
transporter gene,47-48 have been associated with eating disorders
susceptibility but several studies failed to replicate these
findings.37,49-55 The importance of the catecholinergic system
in the etiology of eating disorders have been recently stimulated
by positive findings for the norepinephrine transporter gene.56-
57 Another unreplicated association study in AN includes the
catechol-O-methyl transferase.58 The brain-derived neurotrophic
gene (BDNF) has also been examined for its association with
eating disorders, suggesting its participation in the genetic
susceptibility to eating disorders, mainly restricting anorexia
nervosa.59-60 Conflicting results have also emerged in regard
to the role of estrogen pathway genes in the etiology of anorexia
nervosa.61-62 A recent study, 63 reporting a significant association
between the estrogen receptor beta and bulimia nervosa,
implies that this gene (or linked genes) may be involved in
the etiology of the disorder. These findings are particularly
interesting because the estrogen beta receptor gene is located
in a region of the chromosome 14 that showed suggestive
linkage with bulimia nervosa.19
Branson and coworkers reported a strong association
between BED and variants in the melanocortin-4 receptor gene
(MC4R).64 They identified 24 carriers of MC4R variants among
469 severely obese patients. Stringently diagnosed BED was
present in all 20 (100%) of the 24 obese carriers of MC4R
variants in contrast to only 14.2% among those 120 obese
non-carriers matched for age, sex and body mass index (BMI).
Their findings were not replicated by Hebebrand and colleagues
who investigated a group of 814 obese children and adolescents
and identified 43 carriers of MC4R mutations.65 No evidence
for an increased rate of binge-eating behavior in obese carriers
of MC4R mutations was found. MC4R variants might also be
associated with poor treatment outcome in severely obese
individuals who undergo laparoscopic gastric banding.66
Additional research is still needed for other candidate genes
involved in the neurotransmitter system (e.g., dopamine,
glutamate, opioids) and also in the regulation of feeding and
energy expenditure (e.g., agouti-related protein, neuropeptide
Y, leptin and reproductive hormones).
The Price Foundation of Geneva, Switzerland, funded a series
of studies that have rendered intriguing linkage results for
both anorexia and bulimia nervosa. A number of clinical sites
through North America and Europe were involved in this
cooperative effort. These studies illustrated the importance of
changing the current nosology to better reflect the underlying
structure of eating disorders implying accurate phenotyping in
order to reduce phenotypic and genotypic heterogeneity. Miguel
et al.67 have also addressed the importance of elucidating
specific homogeneous subgroups in genetic studies of other
psychiatric disorders such as obsessive-compulsive disorder
(OCD). These authors highlight that this approach might help
identify subtypes of the disorder under investigation distinctively
transmitted within families due to unique genetic factors and,
therefore, more easily identified with genetic linkage studies.
Kaye and colleagues described the methodology for the first
linkage study of AN of 192 families with at least one affected
relative pair with AN and related eating disorders.68 The initial
f indings showed no l inkage. However, two addit ional
approaches yielded significant linkage. First, the authors
restricted the linkage analysis to a subset of families in which
at least two affected relatives had a diagnosis of the prototypic
AN phenotype – restricting AN. This approach was relevant as
heterogeneity in a sample can reduce underlying linkage
signals. Restricting AN represents a uniquely recognizable
phenotype and one that is quite plausibly influenced by
heritable biological factors. Limiting the linkage analysis to
the restricting AN subset produced evidence for the presence
of a susceptibility locus in chromosome 1.20 In addition, Devlin
et al.18 selected and incorporated core behavioral covariates
(drive for thinness and obsessionality). The inclusion of these
covariates revealed several regions of interest in chromosomes
1, 2 and 13. Accurate phenotyping in genetic analysis is crucial
in the process of identifying genes that contribute for the liability
of psychiatric conditions.
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The only published linkage study of BN reported significant
linkage in chromosome 1019 when using a broad sample of
families with BN. A second peak occurred further p-ter (ter-
minal end of the short arm of the chromosome), which
approached signif icance. Suggestive l inkage was also
observed in chromosome 14. Phenotypic information was
incorporated in the linkage analysis through focusing on
families who had elevated rates of vomiting. This phenotype
was chosen because twin studies in BN had indicated that
vomiting was particularly heritable (72%).69 Significant
linkage was observed in this analysis in the cohort enriched
for vomiting in chromosome 10. Another area suggestive of
linkage was identified in chromosome 14.
This team of researchers has begun to explore the regions
under the linkage peaks for rational candidate genes.70 Both
serotonin 1D and delta opioid receptor genes exhibited
significant association with AN. Future studies should
investigate the role of these receptor genes in the etiology of
AN, possible differential association with subtypes of AN, and
interactions between these genes and other genes involved
with serotonergic and opiodergic function and metabolism.70
Genet ic research in Brazi l :  understanding
populat ion admixture
Gene flow between subpopulations generates chromosomes
made up of segments that have ancestry from different
subpopulations. The admixture proportions of an individual
are defined as the proportions of the individual’s genome that
have ancestry from each subpopulation.71 Studying admixture
is important from a historical and anthropological perspective.
Migration of individuals and populations (and subsequent
mixing) has always played an important role in the evolutionary
history of humans. Since the 15th century, these migrations
have occurred on a larger scale. In the case of the Americas,
populations that were previously isolated for generations came
into contact, and many persons living in North, Central and
South America can trace their ancestry to different continents.
Brazi l ians represent one of the most heterogeneous
populations in the world, resulting from five centuries of
interethnic mating of Portuguese colonizers, African slaves
and the native Amerindians.72-73 The Portuguese-Amerindian
admixture, mating between European men and indigenous
women, began right after the arrival of the first colonizers.
After 1755, it was even stimulated in order to increase the
population and the colonial occupation of the land.74 The native
indigenous tribes went through a significant demographic
decline due to conflicts with the colonizers and maladies to
which they were not adapted.72,75 Africans were forcefully
brought to Brazil in the middle of the 16th century, as slaves,
to work on sugarcane cultivation and, later on, in the
extraction of gold and gemstones and on coffee plantations.
 Approximately half a million Portuguese came to Brazil
between 1500 and 1808, and around 3.5 million Africans
arrived in Brazil during the years of slave trade, between 1551
and 1850.75 After the Brazilian ports were legally opened to
all friendly nations, the country received immigrants from
several parts of the world. According to Callegari-Jacques and
Salzano,76 58% of the immigrants who arrived in Brazil
between 1500 and 1972 were Europeans, 40% were Africans,
and 2% were Asians.
 Brazilians refer to color as a synonym for race, based on
complex phenotypic assessments that take into account, besides
skin pigmentation, other physical characteristics such as hair
type, nose and lip shape. Color is probably preferred to race in
Brazil because it encompasses the continuous aspects of
phenotypes.77 The Brazilian emphasis on physical appearance
rather than ancestry is demonstrated by the fact that the national
demographic census usually includes five self-reported
categories of color. People report whether they are white, black,
mixed, yellow or indigenous. The 2000 national census
revealed that 53% of the population (out of 170 million people)
declared themselves white, 38% mixed, 7% black, .5% yellow,
0.4% indigenous and 0.7% did not report their color or race.78
With the history of five centuries of interethnic mating it is
very unlikely that the color of a Brazilian person predicts his/
her genomic ancestry.
This history of migrations and admixture can be reconstructed
and interpreted using genetic markers. A useful perspective
can be obtained when analyzing chromosomal markers,
maternally transmitted mtDNA markers and Y-chromosome
specific markers, which are transmitted from fathers to sons.
Thus, using genetic markers we can reconstruct history at
the individual and population level, even in the absence of a
historical record.
The study of DNA lineage markers to ascertain the con-
t i nen ta l  ances t r y  o f  B raz i l i an  wh i t e  i nd i v idua l s
demonstrated that the vast majority of Y chromosomes in
white Brazilian males, regardless of their regional source,
were of European origin, with a very low frequency of
sub-Saharan Afr ican Y chromosomes and a complete
absence of Amerindian contribution.79 On the other hand,
by analyzing mtDNA, a surprising high amount of 33%
Amerindian and 28% African contribution to the total
mtDNA pool of white Brazilians was found.80
Brazil is a large territory and because different population
groups moved into diverse par ts of the country, there is
considerable phylogeographical heterogeneity. mtDNA was
analyzed in the four main regions of Brazil and it was found
there was broad agreement with what could be expected from
historical data: a predominance of Amerindian matrilineages
in the Amazon region in the north, a preponderance of African
lineages in the northeast, equal proportions in the southeast,
and European predominance in the south. The most
pronounced levels of admixture were observed in the northeast
and southeast.80 Together, these results confirm historical
records of directional mating in Brazil involving European
males and Amerindian and African females. In addition to the
role that these studies play in understanding Brazilian history,
studying admixture has important applications in the biomedical
field as discussed below.
Studying complex traits: population stratification and
admixture mapping
In the view of classical genetics, diseases are divided into
Mendelian disorders and complex traits. While the former are
attributed to single gene mutations with a single mode of
inheritance, the latter are thought to result from multiple genes,
each playing a small and interactive role in the susceptibility
to the diseases.81 But discrepancy in results could also be
attributed, at least par tially, to the presence of residual
population stratification.
The case-control design is a widely used approach for
investigating associations between candidate genes and
dichotomous disease traits. Associations between genotype and
outcome may be confounded by unrecognized population
stratification. In general, population stratification exists when
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the total population has been formed by admixture between
subpopulations and when admixture proportions (defined
as the proportions of the genome that have ancestry from
each subpopulation) vary between individuals. If the risk of
disease varies with admixture proportions, this will confound
associations of disease with genotype at any locus where
allele frequencies vary between subpopulations. In other
words, population stratification exists if the gene under study
shows marked variation in allele frequency across subgroups
of population and if these subgroups also differ in their
baseline risk of the disease. This kind of bias will always
increase the chances of a false-positive significance test if
the candidate gene has no causal effect on the risk of
disease. What is at issue is how much variation in allele
frequencies and disease rates there is between subdivisions
of the major ethnic categories.82
Part of the concern about the potential magnitude of the
population stratification problem derives from the observation
that the literature on candidate gene associations is marked
by a high frequency of non-replication studies.82 Critical
methodological components to these failures are small
sample sizes and lack of dense genotyping. But at least
some of the discrepancy in results could be imputed to re-
sidual population stratification.
The concern with population strati f ication would be
dimin ished by care fu l  a t tent ion to  the pr inc ip les  o f
epidemiological study design, including the selection of
controls that are representative of the source population of
cases and by making some effort to control ethnicity by
restriction, matching, or stratified or multivariate analysis.
If the confounder - admixture proportions - can be measured
accurately, control can be achieved by modeling its effects
in the analysis. More detailed information on ethnicity is
necessary, meaning that individuals must be allocated to
the finest ethnic origin categories that can reliably be
determined, and individuals from mixed-ethnicity families
must be treated appropriately.82
No candidate gene association should be considered
“confirmed” until replicated at least by multiple well-designed
studies in different populations where any effects of population
stratification or other methodological biases are unlikely to
act in a consistent manner.
The genetic structure of admixed human populations could
be explored to localize genes that underlie ethnic variation in
diseases or traits of interest. This approach is named “admixture
mapping”.71  Whole-genome scanning under the admixture
mapping strategy consists of scanning the genome and
identifying the regions with an excess of one ancestry in the
cases versus the controls assuming that this ancestry carries
the predisposing allele.83 As compared to association studies,
admixture mapping has two key advantages: it typically requires
only 2,000-3,000 ancestry-informative markers for a genome
search (compared with at least 350,000 markers for whole-
genome association studies) and it is less susceptible to allelic
heterogeneity. The ability to detect a disease locus depends
only on whether the pool of high-risk alleles is differentially
distributed between subpopulations; it does not matter whether
there are a few common risk-associated alleles or many rare
risk-associated alleles at the locus under study.71
Admixture mapping can be applied only when admixture
has been occurring at least for two generations. The most
obvious applications are to populations formed by admixture
between groups originating on different continents that
occurred as a result of European maritime expansion during
the past few hundred years, Brazilians being a good example.
There are not many diseases for which epidemiological
criteria support genetic explanations for ethnic variation in
risk, but include some of the leading causes of morbidity
and mortality, such as type 2 diabetes, hypertension, obesity,
and coronary disease.
Implications for the genetic research of eating
disorders in Brazil
The most rigorous genetic studies of anorexia nervosa and
bul imia nervosa have been conducted with relat ively
homogeneous populations with samples selected to represent
only one ethnic group. Hence, the heritability of these disorders
among different ethnic groups is unknown.
If a broader understanding of the genetic contribution to the
etiology of eating disorders is to be pursued, the unique
implications to start a large-scale study of eating disorders
genetics in a country like Brazil need to be addressed.
Collaborative efforts are of utmost importance. Under the
coordination of a principal investigator and the funding provided
by a governmental or private institution, the number and
location of sites need to be determined and contacted to get
their collaboration. Several factors need to be carefully
evaluated: the availability of trained academic collaborators
who are experienced in assessing eating-disordered individuals
in order to establish consistent behavioral assessment
procedures across sites and the sites must have a significant
number of records of individuals who had been previously
treated for eating disorders. Therefore it will be possible to
contact the necessary number of subjects who had previously
been in treatment at the eating disorders treatment centers.
The history of the treatment of eating disorders in Brazil dates
back in the late 80’s when academic centers started their
programs located in Sao Paulo, Rio de Janeiro and Porto Ale-
gre. New eating disorders treatment centers in other areas of
the country are beginning to develop and contact with these
new centers is crucial to address the possibility of having their
collaboration to recruit individuals who are representative of
other Brazilian regions.
The core site, with the help of the other sites, will develop a
protocol for ascertaining individuals with eating disorders and
controls, including psychological evaluations, collecting blood
samples for DNA analysis, and obtaining informed consent.
The protocol has to be separately approved by each site’s Ethics
Committee. Following informed consent and completion of all
assessment procedures, research participants will give
peripheral blood samples that will be stored at the core site’s
molecular genetic laboratory for DNA extraction, genotyping,
and quantitative genetic analysis. Such a project has already
been developed through a cooperative arrangement between
the Price Foundation, the University of Pittsburgh, and other
academic sites in North America and Europe, resulting in the
largest research on the genetics of eating disorders. The
experience obtained by these investigators can be helpful in
carrying out a similar project in Latin America.
As mentioned before, Brazil is a large country with a highly
admixed population and the proportions of admixture vary across
different regions (e.g., Rio de Janeiro and Sao Paulo are large
cities located in the southeastern region where levels of
admixture are higher than in Porto Alegre, which is located in
the south of Brazil). In order to avoid population stratification
in this situation, it would be best to conduct the genetic
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research in only one of the Brazilian regions where the levels
of admixture are known (it is not possible to limit data collection
to one ethnic group since there is not such a group in this
country). On the other hand, it is important to consider the
low prevalence of eating disorders, which means a very long
period to obtain an appropriate sample size if data collection
is limited to only one geographic region.
Would Brazilian participants be able to accurately report
their ancestry information? Certainly not after five centuries of
interethnic crosses. A study of Parra et al. demonstrated that
at the individual level there was significant dissociation of
skin color, determined by physical evaluation, and African
ancestry, estimated by molecular markers.77 This study shows
that, in Brazil, people might be classified on the basis of the
presence of certain alleles at a small number of genes that
have impact on the physical appearance, while ignoring all
the rest of the genome. It also points to the fact that the
allocation of research participants to the finest ethnic origin
cannot be reliably determined.
In a linkage study of complex traits such as eating disorders,
population isolates offer distinct advantages over large out bred
populations. They tend to exhibit stronger disequilibrium, which
makes disequilibrium mapping a promising search technique.
Also, because of founder effects, the number of genes
underlying a trait is presumably smaller in such populations.
Brazilian population is the opposite of a population isolate
with high admixture and high allelic heterogeneity. This might
have an important disadvantage for the mapping of susceptibility
alleles as compared to population isolates in linkage studies.
Also important genes in population isolates may be unimportant
in other populations, limiting comparison of results among
studies with population isolates and admixed groups.
In the case of an association study, if the idea is to ascertain
participants from different areas of the country in order to
obtain a large sample, then genomic information should be
made available. Ancestry-informative markers will be necessary
to accurately measure the admixture proportions of the
individuals and control for it as a confounder. Tests for allelic
association with the disease can then be adjusted for the
confounder in this kind of study. For example, African American
and Hispanic American populations have been investigated by
means of admixture mapping in the study of hypertension and
type 2 diabetes where confounding by populations stratification
was made possible by using a panel of markers informative for
ancestry and Bayesian computationally intensive methods for
statistical analysis.83-84 The genetics of complex traits is yet to
be investigated in other countries with such admixed
populations by means of admixture mapping.
In summary, the genetic research of eating disorders in Brazil
faces many challenges. The first relates to the high cost of
this kind of research and to the fact that it is very time-
consuming, along with the need to get various eating disorders
centers to cooperate, with different levels of clinical and
research expertise among the first centers in Sao Paulo, Rio
de Janeiro and Porto Alegre compared to the new centers.
The technical issues refer to the specifics of genetic research
with such an admixed population and the strategies to be
utilized in order to overcome these difficulties.
The future of eating disorders genetics research:
Brazil and Latin America
During the past 15 years, our ideas on the etiology of eating
disorders have gone through a major revolution. The field is
now compelled to integrate the knowledge of the role of genetics
along with social, psychological and family factors to
understand the risk for these disorders. It is also clear, that
until now, consistent genetic research in eating disorders has
been developed in Europe and North America. The development
of a genetic research project in other countries is essential
and will integrate a new perspective in the biological etiology
of eating disorders. As very large samples are necessary to
avoid false negative results, and case finding in eating disorders
is particularly challenging, it becomes clear that a major
collaborative genetics initiative not only in Brazil, but also in
Latin America would represent the realistic possibility of studying
the genetics of eating disorders in the context of inter ethnic
groups. Since there is wide agreement among human
geneticists and anthropologists that, from a biological
standpoint, human races do not exist,77 this kind of research
might be relevant to improve the knowledge of complex traits
such as eating disorders once it might represent an approach
that brings genetic and cultural (in this case, different
ancestries) factors together.
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